Roche: Leveraging the Genentech Acquisit Diagram

失败与踩坑

• Heavily fined by the EU in the 1990s for…
• Betting on long-acting interferon for He…
• During the 2015-2018 patent cliff
• Initial management disagreements followi…
• Missing out on mRNA vaccine technology i…

关键成功要素

• The core of a century of operation is de…
• Betting on Genentech in 2009 against Wal…
• Continuously performing cross-pollinatio…
• Investing in bispecific antibodies and n…
• 20%
• Transforming the diagnostics business fr…

经验教训

• The most dangerous success for a large p…
• M&A is a good lever
• The patent cliff is not the end
• Technological diversification exposes th…
• Barriers created by the dual monopoly of…
• External innovation (such as introducing…